Terumo buys OrganOx in $1.5B deal
Source: SeekingAlpha
2025-08-25 01:54:07 ET
The development marks Terumo’s strategic entry into the organ transplantation-related sector by acquiring OrganOx to enhance organ preservation, improve transplant outcomes, and increase access for patients in need....
Read the full article on Seeking Alpha
For further details see:
Terumo buys OrganOx in $1.5B deal
Terumo Corporation ADR
NASDAQ: TRUMY
TRUMY Trading
1.01% G/L:
$13.04 Last:
43,678 Volume:
$12.6301 Open:
TRUMY Latest News
January 06, 2026 08:29:00 am
Terumo Launches SurTract(TM) Safety Syringe in the United States, Powered by Roncadelle Operations' SafeR® Passive Safety Technology
October 29, 2025 03:00:00 pm
Geisinger and Terumo Neuro Advance Stroke Education and Neurovascular Innovation in Recognition of World Stroke Day 2025
